|
Jagsonpal Pharmaceuticals Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
1683.88 Cr.
|
P/BV
|
8.54
|
Book Value (Rs.)
|
29.67
|
|
52 Week High/Low (Rs.)
|
328/110
|
FV/ML
|
2/1
|
P/E(X)
|
74.96
|
|
Bookclosure
|
08/01/2025
|
EPS (Rs.)
|
3.38
|
Div Yield (%)
|
0.79
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 29.87 | 34.81 | 27.32 | 21.87 | 9.41 |
| | | | | | |
| Net CashFlow From Operating Activities | 35.17 | 46.66 | 5.60 | 28.22 | 11.25 |
| Net Cash Used In Investing Activities | -24.55 | -57.67 | -26.21 | -2.26 | -10.76 |
| Net Cash Used From Financing Activities | -8.91 | -0.46 | -12.30 | -6.83 | -0.94 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 1.71 | -11.47 | -32.91 | 19.13 | -0.46 |
| Cash And Cash Equivalents Begin of Year | 11.05 | 22.53 | 58.94 | 39.81 | 38.53 |
| Cash And Cash Equivalents End Of Year | 12.76 | 11.05 | 26.03 | 58.94 | 38.07 |
